• Educational resources
  • Events
  • Expert Panel
  • Learning Hub
    Learning Hub
    • EoE Learning Hub
    • Bullous Pemphigoid Learning Hub
    • Chronic Spontaneous Urticaria Learning Hub
    • COPD Learning Hub
    • Rhinology Learning Hub
    • Type 2 Asthma Learning Hub
    • Prurigo Nodularis Learning Hub
    • Atopic Dermatitis Learning Hub
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT
  • Contact us

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 - 4.0 - 10/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: The NetherlandsChange country/region

Educational Resources

Categories
Dermatology: 
  • Atopic dermatitis
  • Bullous pemphigoid
  • Chronic pruritus of unknown origin
  • Chronic spontaneous urticaria
  • Prurigo nodularis
Gastroenterology: 
  • Eosinophilic esophagitis
Pulmonology: 
  • Asthma
  • Chronic obstructive pulmonary disease
  • IL-33
Rhinology: 
  • Chronic rhinosinusitis with nasal polyps
Filters
Topic: 
  • Burden of disease
  • Pathophysiology
  • Guidelines and recommendations
  • Clinical management
  • Co-existing type 2 inflammatory diseases
Format: 
  • Expert Video
  • Podcast
  • Slide presentation
  • Infographic
  • Video animation
  • Interactivity
Length: 
  • Short (<5 minutes)
  • Medium (5-15 minutes)
  • Long (> 15 minutes)
Sort by: Newest
  • Newest
  • Oldest
  • A-Z
  • Z-A
Systemic Inflammation in AD – Beyond the Skin
Dermatology
4 min
expert video

Systemic Inflammation in AD – Beyond the Skin

Disease Modification in AD
Dermatology
3 min
expert video

Disease Modification in AD

What is Early Intervention in AD?
Dermatology
3 min
expert video

What is Early Intervention in AD?

Within and Beyond the Skin: New Perspectives on the Role of Type 2 Inflammation in AD
Dermatology
15 min
expert video

Within and Beyond the Skin: New Perspectives on the Role of Type 2 Inflammation in AD

Emerging Data on Advanced Systemic Treatments for Children With AD
Dermatology
15 min
expert video

Emerging Data on Advanced Systemic Treatments for Children With AD

CRSwNP: A Chronic Type 2 Inflammatory Disease
Rhinology
2 min
expert video

CRSwNP: A Chronic Type 2 Inflammatory Disease

Describing Disease Control in PN
Dermatology
5 min
expert video

Describing Disease Control in PN

Can early intervention modify the course of AD?
Dermatology
5 min
expert video

Can early intervention modify the course of AD?

Can targeting IL-4 and IL-13 have an effect on relieving the burden of atopic and non-atopic comorbidities in AD?
Dermatology
5 min
expert video

Can targeting IL-4 and IL-13 have an effect on relieving the burden of atopic and non-atopic comorbidities in AD?

Barrier disruption in AD and the development of environmental and food allergies
Dermatology
5 min
expert video

Barrier disruption in AD and the development of environmental and food allergies

Can advanced systemic therapies modify pathomechanisms in AD?
Dermatology
5 min
expert video

Can advanced systemic therapies modify pathomechanisms in AD?

Current systemic therapies have been shown to induce remission in a subset of AD patients
Dermatology
5 min
expert video

Current systemic therapies have been shown to induce remission in a subset of AD patients

    1
    ...
    202122
    ...
    29